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doi:10.1016/j.jmii.2012.01.003Background: Pseudomonas aeruginosa (P. aeruginosa) sepsis is a fetal disease with rapid
progressive shock for infants and children in hospital and in the community, without initial
treatment with appropriate antibiotics. Because underlying risk factors remain unclear for
affected patients, it is still difficult for early diagnosis and therapy. Recently, ABO blood group
antigens were associated with several infectious diseases. However, it was not reported
whether the ABO blood group could be the clinical implications for pediatric Pseudomonas
sepsis.
Methods: This study retrospectively reviewed the medical records of 23 infants and children
with P. aeruginosa sepsis, who were hospitalized at Kaohsiung Chang Gung Memorial Hospital
from 2003 to 2009.
Results: Eight cases had nosocomial infections, with a higher mortality rate (50%) than 15 cases
(26.7%) in the community. Thirteen patients (86.7%) with community-acquired sepsis were
infants, significantly younger than the nosocomial cases. ABO blood group antigens were known
in 21 cases and B phenotype was the most significant. In the community-acquired group, fever
and diarrhea were the most prevalent symptoms on initial presentation. Moreover, pneumo-
nitis was the most concomitant disease in fatal cases.
Conclusion: Blood group B was highly associated with pediatric P. aeruginosa sepsis. This could
be a risk factor, and play an important role for the pathogenesis of P. aeruginosa sepsis.
Furthermore, if a previously healthy infant with fever and diarrhea suddenly had septict of Pediatrics, Kaohsiung Medical University Hospital, Graduate Institute of Medicine, Kaohsiung
u 1st Road, Sanmin District, Kaohsiung City 807, Taiwan.
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110 K.-C. Kuo et al.presentation, P. aeruginosa infection should be considered. In addition, more intensive care
could be needed for such blood group B pediatric patients, if pneumonitis was concomitant
on admission for the high mortality rate.
Copyright ª 2012, Taiwan Society of Microbiology. Published by Elsevier Taiwan LLC. All rights
reserved.Introduction
Pseudomonas aeruginosa (P. aeruginosa) sepsis often occurs
in patients with malignancies, immunodeficiency, cystic
fibrosis or burns.1 These immunocompromized patients
have a high mortality rate. The infections may result from
strains acquired in the community or the hospital, but are
mostly nosocomially acquired.2,3 Community-acquired
P. aeruginosa sepsis has been reported in previously
healthy patients, especially infants and in children.4e6
However, initial antibiotics for community-acquired sepsis
in previously healthy infants and children do not include
effective anti-pseudomonal agents empirically, although
gram negative organisms were considered.7 Reports about
pediatric community-acquired P. aeruginosa bacteremia or
sepsis in northern and central Taiwan by Huang et al5 and
Wu et al,4 respectively, indicated that a high mortality rate
was noted with an initial inappropriate antimicrobial
regimen and septic shock. They also showed that it was not
rare in pediatric populations and that its early clinical
manifestation was difficult to determine. Therefore, we
conducted this retrospective study to unearth more clinical
implications of the infectious disease, sampled from pedi-
atric cases in Kaohsiung Chang Gung Memorial Hospital in
southern Taiwan. Recently, several experimental and clin-
ical research studies have postulated that blood carbohy-
drates of blood group substances could interact with
microbial surface lectins, which could be associated with
pathogenesis in infection.8e15 In a review article, the
relationship between infection diseases and selection for
ABO blood group antigens was mentioned and organized by
Anstee.8 We believe that this may play a role in this
infectious disease, which has not been previously reported.
Thus, ABO blood groups of our cases were also evaluated in
this study. We reviewed medical records of children with P.
aeruginosa sepsis hospitalized at our hospital and report 23
cases during a 7-year period. In this study, we describe the
clinical characteristics of these cases and try to delineate
the features of such cases.Materials and methods
Study population and definition
This retrospective cross-sectional study was conducted at
the Kaohsiung Chang Gung Memorial Hospital, a medical
center with 170 pediatric ward beds and 53 intensive care
unit beds providing primary and tertiary care for infants
and children in southern Taiwan. The annual ER census in
this hospital is approximately 55,000 visits. The database at
our clinical microbiology laboratory was reviewed in orderto identify patients with P. aeruginosa bacteremia from
January 1, 2003 to August 31, 2009. Community-acquired
bacteremia was defined as a positive blood culture taken
on or within 48 hours of admission. Only the first bacter-
emic episode for each patient was included in the ana-
lysis.Patients with polymicrobial bloodstream infections
were excluded.The case definition was a patient with blood
culture positive for P. aeruginosa and clinical and labora-
tory evidences of infection. Antimicrobial therapy was
considered ‘appropriate’ when the initial treatment
included at least one antibiotic that was active in vitro
against the causative microorganisms, and administered
within 24 hours of blood drawn for bacterial culture. The
study methods and definitions were as described pre-
viously.Medical records of these cases were retrospectively
reviewed for demographic data, underlying diseases, clin-
ical manifestations, laboratory data, clinical outcome,
antibiotic therapy and antibiotic susceptibility of P. aeru-
ginosa. All enrolled cases were categorized by definition
into the two groups of community-acquired and nosocomial
modalities. Moreover, patients in the community-acquired
group were divided into two subgroups, nonfatal and fatal.
Babies born in the Kaohsiung Chang Gung Memorial
Hospital all received the blood group antigens test of ABO
and RH phenotype free of charge and with their parents’
agreement. In this study, we randomly sampled 100
newborns born in our hospital during the period and
recorded their blood group phenotype as the control group
for these cases in ABO blood group analysis.
Statistical analysis
Statistical Package for the Social Sciences (SPSS) for
Windows (Version 12.0; SPSS Inc., Chicago, IL, USA) was
used for analysis of data. Continuous variables were
analyzed by Student t test or Mann-Whitney U test. Cate-
gorical variables were compared by means of Chi-square
test or Fisher’s exact test. The prevalence of the samples
and the population was compared with goodness of fit test.
Statistical significance was determined at p < 0.05.Results
We identified 26 infants and children with P. aeruginosa
bacteremia in the study period. Three cases lacking clinical
and laboratory evidence of sepsis and treatment without
anti-pseudomonas agents were excluded. Therefore,
a total of 23 cases were evaluated in our study. Fifteen
cases (65%) were enrolled in the community-acquired group
and 8 cases (35%) in the nosocomial group. Their clinical
manifestations are listed in Table 1. Of the 23 cases with
Table 1 Pseudomonas aeruginosa sepsis in our pediatric
patients
Total (n Z 23) Nosocomial
group
Community
group
p
(n Z 8) (n Z 15)
Mortality 4 (50)a 4 (26.7) 0.371
Sex
Male 3 (37.5) 8 (53.3) 0.667
Female 5 (62.5) 7 (46.7)
Age (mo) 86.7  21.8 17.5  8.4 0.02*
Infant (1 y) 0 (0) 13 (86.7) <0.001*
Children(>1 y) 8 (100) 2 (13.3)
ABO blood group 7 14 NS
A 0 1
B 5 8
O 2 5
* p < 0.05, statistically significant; NS Z not significant.
a Numbers in parentheses, percent.
ABO blood group and pediatric Pseudomonas aeruginosa sepsis 111P. aeruginosa sepsis (aged 4 monthse17 years), 11 were
male and 12 were female. The mean age of the community-
acquired group (17.5  8.4 months) was significantly less
than that of the nosocomial group (86.7  21.8 months).
Thirteen cases (86.7%) were infants < 1 year of age in the
community- acquired cases. The other two cases (13.3%)Table 2 Clinical manifestations of community-acquired P. aeru
Characteristics Total case
(n Z 15)
Sex (male:female) 8:7
Fever 15 (100)a
<3 days 4 (27)
3 days 11 (73)
Diarrhea 12 (80)
Vomitus 5 (33)
Tachycardia (150/min) 10 (67)
Hyponatremia (130 mEq/L) 7 (47)
Leukocyte count < 5000/mm3 9 (60)
Platelet count < 105/mm3 4 (27)
Elevated AST (>60 IU/dL) 5 (33)
Appropriate therapy 11 (73)
Concomitant diseases
Infectious enteritis 6
Pneumonitis 4
Cellulitis 2
Urinary tract infection 3
AST Z aspartate aminotransferase; NS Z not significant.
* p < 0.05, statistically significant.
a Numbers in parentheses, percent.were 3 and 11 years of age. The 3-year-old boy had
P. aeruginosa sepsis initially, and acute lymphocytic
leukemia was proven later. The 11-year-old girl was a case
of biliary atresia and received the Kasai procedure before.
All of the nosocomial cases were beyond infantile age. The
mortality rate was 26.7% in the community- acquired group,
and 50% in the nosocomial group. Although the mortality
of the nosocomial group was higher than that of the
community-acquired group, the difference was not statis-
tically significant. Moreover, of the eight fatal cases in the
two groups, seven cases (87%) were complicated with
pneumonitis (patch infiltration with or without pleural
effusion) validated by chest X-ray and they died from
respiratory failure. By reviewing ABO blood grouping of 21
cases, 13 cases with a B blood group and 7 cases with O
blood group were significantly more than the single A blood
group. This finding has not been mentioned in any clinical
study of P. aeruginosa sepsis with the exception in cystic
fibrosis, to the best of our knowledge.
The detailed clinical characteristics of community-
acquired P. aeruginosa sepsis on admission are shown in
Table 2. They occurred during May to October in 13 cases
(87%). Fever (100%) and diarrhea (80%) were the most
common symptoms. Because of other symptoms such as
cough, coryza, headache or lethargy being extremely rare
or non-specific in previous studies, they are not listed in
Table 2. Leukopenia (white blood cell count < 5000/mm3)
was present in 9 cases (60%), thrombocytopenia (platelet
count < 100,000/mm3) in 4 cases (27%), and hyponatremia
(serum Na < 130 mEq/L) in 7 cases (47%) on admission. In 12
cases with diarrhea, 50% had P. aeruginosa enteritis provenginosa sepsis on admission
Fatal case Non-fatal case p
(n Z 4) (n Z 11)
3:1 5:6 0.569
2 2
2 9 0.516
4 8 0.516
2 3 0.560
3 7 NS
2 5 NS
2 7 NS
2 2 0.516
2 3 0.580
2 9 0.516
2 4 NS
4 0 0.001*
0 2 NS
0 3 NS
112 K.-C. Kuo et al.by a positive pure single stool culture. All fatal cases had
pneumonitis with patch infiltration or pleural effusion;
surviving patients did not. Two nonfatal cases had
P. aeruginosa cellulitis and abscess on admission, and
received plastic debridement. Moreover, three non-fatal
cases had an initial concomitant E. coli urinary tract infec-
tion. The incidence rates of thrombocytopenia, hypona-
tremia, elevated AST, inappropriate therapy and vomitus
were higher in the fatal cases than in the nonfatal cases but
the difference was not significant. Immunological studies
were performed in eight patients. A girl had hypogamma-
globulinemia, a boy had mild natural killer (NK) cell defi-
ciency, and another five cases had mild low serum IgA levels
(<70 mg/dL).
All 15 isolates of P. aeruginosa were 100% susceptible to
amikacin, gentamicin, piperacillin, ciprofloxacin and imi-
penem; one was resistant to ceftazidime and cefepime.
Most cases (73%) were treated with an appropriate
regimen. However, the rate of an inappropriate initial
antibiotic regimen was higher in the fatal cases (50%) than
in the nonfatal cases (18%).
In Table 3, the ABO blood group phenotypes of the 100
newborns, which were sampled randomly as the control
population, showed 24, 20, 46 and 10 cases with A, B, O and
AB blood groups, respectively. The prevalence of this
newborn control group in ABO blood phenotypes was
consistent with Taiwanese reference of the Taiwan Blood
Services Foundation under the analysis of goodness of fit
test (pZ 0.311). When compared with the control group of
these newborns, the prevalence of blood phenotype B was
statistically significant in our pediatric P. aeruginosa sepsis
cases. This finding indicated that presentation of human
ABO blood group antigens was highly associated with
pediatric P. aeruginosa sepsis and may play a role in the
pathogenesis of this organism.Discussion
We conducted a retrospective study of 23 pediatric P.
aeruginosa sepsis cases at a single institute and docu-
mented 15 community-acquired cases and 8 nosocomial
cases during 7 years. This study may lead to a better
understanding of pediatric P. aeruginosa sepsis. When
compared with the nosocomial group, the community-
acquired group had a lower mortality rate and significantly
higher prevalence in infants. These findings were in accor-
dance with the results of previous studies.2e6,16 However,
our results showed more cases of community-acquiredTable 3 Comparison between P. aeruginosa sepsis cases and ne
Group blood
phenotype
Cases (n Z 21) Control (n Z
A 1 24
B 13 20
O 7 46
AB 0 10
CI Z confidence interval; OR Z odds ratio.
* p < 0.05, statistically significant.bacteremia than those in the nosocomial classification,
which did not match previous reports.3,16 This could be
explained by the following reasons: firstly, our limitation
was a small number of cases enrolled during this period;
secondly, empiric antibiotics with at least one anti-
pseudomonal agent for febrile episodes were usually given
to our immunocompromized patients, who were initially
admitted for their underlying diseases such as leukemia,
prematurity and immunodeficiency. In our research, the
antimicrobial susceptibility of all agents to this bacillus was
still high in these cases.
The ABO (H) antigens are not only confined to red cells
but also are widely expressed in body fluids and tissues,
which are regulated by the secretor gene (FTU2).17 The
gene encodes a glycosyltransferase, which transfers N-
acetyl D-galactosamine (group A) or D-galactose (group B)
to the nonreducing ends of glycans on glycoproteins and
glycolipids. Recently, considerable evidence has been
accumulated showing that carbohydrate-containing blood
group substances represent prime candidates for the
specific interaction with microbial surface lectins in infec-
tious diseases.8,14,18 Pseudomonas aeruginosa produces two
lectins in close association with virulence factors, PA-IL and
PA-IIL, which bind to galactose- and fucose/mannose-
containing glycoconjugates, respectively.13,18e22 These
experimental studies implied that these lectins were rela-
tive to their putative roles in cell surface adhesion, biofilm
formation, and host recognition associated with Lewis, P,
ABO (H), or Bombay blood group antigens.18e21,23,24 More-
over, these interactions of the carbohydrate containing
substances over cells surface, virus, or bacteria played an
important role in the pathway of innate and adaptive
immunity for infections. Characteristics of the interaction
between host glycoconjugation and organism lectins were
discovered recently by researches. There are examples of
infectious diseases in which the severity of infection can be
directly linked to the ABO phenotype. Previous studies
revealed that presentation of the ABO blood group antigen
was highly associated with some bacteria, such as
Helicobacter pylori, Haemophilus influenzae, Neisseria
meningitidis, and Streptococcus pneumoniae.9e12,15,25
Therefore, the survey of ABO blood group correlation with
disease was included in this study. Pseudomonas aeruginosa
was the causative microorganism in chronic purulent otitis
externa and in pneumonitis with cystic fibrosis. Clinical
evidence was offered to indicate blood group A phenotype
was associated with human otitis externa or chronic otitis
media, which might be P. aeruginosa lectins apparently
adhering to GalNAc (N-acetyl-galactosamine) as terminalwborn control group
100) OR (95% CI) p
0.158 (0.020e1.242) 0.072
6.5 (2.373e17.808) <0.001*
0.587 (0.218e1.578) 0.288
0.27
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were unlikely to play a major role in susceptibility to P.
aeruginosa infection in patients with cystic fibrosis.24,28
This could be explained by the fact that the ABO blood
group antigen plays a different role in different populations
and infectious diseases. According to reference of the
Taiwan Blood Services Foundation, the prevalence of the
ABO blood group was, respectively, phenotype O (44%), A
(26%), B (24%), and AB (6%) in the Taiwanese population.
Surprisingly, our study revealed that the B (62%) and O (33%)
phenotypes were the most predominant in the ABO blood
group antigen incidence of these patients with P. aerugi-
nosa sepsis, which has not been published in English liter-
ature. In a further statistic analysis of ABO group antigens,
our results indicated that blood phenotype B was the
greatest risk factor associated with pediatric P. aeruginosa
sepsis (odd ratio Z 6.5). The result was at first reported in
the clinical implications of human P. aeruginosa bacteremia
or sepsis, which need further experimental and clinical
studies.
In Taiwan, P. aeruginosa sepsis is not rare in previously
healthy infants and children. This infection might be the
first manifestation of an underlying medical problem, such
as malignancy or immunodeficiency. In this study, there
were 14 previously healthy cases found in 15 cases with
community-acquired sepsis. Only three cases of ALL,
hypogammaglobinemia and mild NK cell deficiency were
diagnosed by following studies. Community-acquired
P. aeruginosa sepsis in previously healthy children signifi-
cantly occurred at an infantile age, which was found in this
study and previous reports. This could be explained by the
fact that infants had lower and fluctuant serum IgA levels,
which will be sustainable until the age of 4 years. There-
fore, healthy infants were more susceptible to P. aerugi-
nosa infections than children beyond the age of 1 year.
Pneumonitis, with or without pleural effusion, was
a concomitant disease in all four fatal cases. Previous
literature has demonstrated selective IgA deficiency asso-
ciated with P. aeruginosa pulmonary infection, and this
indicates that the cell wall components of this gram
negative organism may induce the loss of cellular effector
function by serum IgA cleavage.29e31 We considered that
P. aeruginosa sepsis with pneumonitis could have a higher
mortality rate and severity by more immune system
disruption. Our findings also agreed with these opinions,
although we did not have enough evidence. This implies
that the mortality rate may increase, while P. aeruginosa
bacteremia is accompanied with pneumonitis on admission,
although an appropriate regimen was used. In addition, the
prevalence of this isolate in stool culture was 50% in all
community-acquired sepsis cases with diarrhea. This indi-
cated that concomitant gastrointestinal infections may
have played a role in pathogenesis. This is consistent with
earlier findings, suggesting that the initial infection route of
community-acquired sepsis might be from P. aeruginosa
enteritis in infants.5,32 We suggest that more intensive
care, such as early intubation or inotropic agents, may be
considered initially for these patients with pneumonitis.
In conclusion, we found that B or O phenotypes of ABO
blood group antigens were associated with P. aeruginosa
sepsis or bacteremia in infants and children; the B blood
phenotype was statistically significant. They may play animportant role in the pathogenesis of P. aeruginosa sepsis.
In previously healthy infants and children, partial humoral
system deficiency was the most apparent in this study,
especially transient low serum IgA level. In addition,
empiric antimicrobial therapy for sepsis should include at
least one aminoglycoside or anti-pseudomonal agent, if the
patient is an infant with fever and diarrhea, developing
a septic appearance suddenly during the warm season. If
these patients’ chest X-rays revealed pneumonitis with
patch infiltration or pleural effusion initially, they may
need more intensive care in the initial therapeutic strategy.
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